Exact Mass: 843.3973698
Exact Mass Matches: 843.3973698
Found 23 metabolites which its exact mass value is equals to given mass value 843.3973698,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Proglumetacin
M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AB - Acetic acid derivatives and related substances C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D006133 - Growth Substances > D010937 - Plant Growth Regulators > D007210 - Indoleacetic Acids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
Anabaenopeptin A
CONFIDENCE standard compound; UCHEM_ID 4356; NaToxAq - Natural Toxins and Drinking Water Quality - From Source to Tap (https://natoxaq.ku.dk)
proglumetacin
M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AB - Acetic acid derivatives and related substances C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D006133 - Growth Substances > D010937 - Plant Growth Regulators > D007210 - Indoleacetic Acids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
2-[[3-Benzyl-9-[2-(4-hydroxyphenyl)ethyl]-6,7-dimethyl-2,5,8,11,14-pentaoxo-12-propan-2-yl-1,4,7,10,13-pentazacyclononadec-15-yl]carbamoylamino]-3-(4-hydroxyphenyl)propanoic acid
methyl 8-{[N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl]oxy}nonanoate
C35H59N2O21- (843.3610143999999)
methyl 8-{[N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl]oxy}nonanoate
C35H59N2O21- (843.3610143999999)
FC131 (TFA)
FC131 TFA is a CXCR4 antagonist, inhibits [125I]-SDF-1 binding to CXCR4, with an IC50 of 4.5 nM. Anti-HIV activity[1].
2-[({3-benzyl-2,5,11,14-tetrahydroxy-9-[2-(4-hydroxyphenyl)ethyl]-12-isopropyl-6,7-dimethyl-8-oxo-1,4,7,10,13-pentaazacyclononadeca-1,4,10,13-tetraen-15-yl}-c-hydroxycarbonimidoyl)amino]-3-(4-hydroxyphenyl)propanoic acid
(2s)-2-({[(3s,6s,9s,12s,15r)-3-benzyl-2,5,11,14-tetrahydroxy-9-[2-(4-hydroxyphenyl)ethyl]-12-isopropyl-6,7-dimethyl-8-oxo-1,4,7,10,13-pentaazacyclononadeca-1,4,10,13-tetraen-15-yl]-c-hydroxycarbonimidoyl}amino)-3-(4-hydroxyphenyl)propanoic acid
(2s,4r)-4-[({2-[(1r,3r)-1-(acetyloxy)-3-[(2s,3s)-2-({hydroxy[(2r)-1-methylpiperidin-2-yl]methylidene}amino)-3-methyl-n-{[(3-methylbutanoyl)oxy]methyl}pentanamido]-4-methylpentyl]-1,3-thiazol-4-yl}(hydroxy)methylidene)amino]-5-(4-hydroxyphenyl)-2-methylpentanoic acid
(2s)-2-({[(3s,6s)-3-benzyl-2,5,11,14-tetrahydroxy-9-[2-(4-hydroxyphenyl)ethyl]-12-isopropyl-6,7-dimethyl-8-oxo-1,4,7,10,13-pentaazacyclononadeca-1,4,10,13-tetraen-15-yl]-c-hydroxycarbonimidoyl}amino)-3-(4-hydroxyphenyl)propanoic acid
4-[({2-[1-(acetyloxy)-3-(2-{[hydroxy(1-methylpiperidin-2-yl)methylidene]amino}-3-methyl-n-{[(3-methylbutanoyl)oxy]methyl}pentanamido)-4-methylpentyl]-1,3-thiazol-4-yl}(hydroxy)methylidene)amino]-5-(4-hydroxyphenyl)-2-methylpentanoic acid
5-hydroxy-n-[6,13,16,21-tetrahydroxy-2-(1-hydroxyethyl)-5-[(4-methoxyphenyl)methyl]-4,11-dimethyl-15-(2-methylpropyl)-3,9,22-trioxo-8-(sec-butyl)-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-3,4-dihydro-2h-pyrrole-2-carboximidic acid
C41H61N7O12 (843.4377986000001)
2-[(2-{[2-({2-[(4-amino-8-{[(2,3-dihydroxyphenyl)(hydroxy)methylidene]amino}-1,3-dihydroxyoctylidene)amino]-1,3-dihydroxypropylidene}amino)-1-hydroxy-5-(n-hydroxyformamido)pentylidene]amino}-1-hydroxy-3-(c-hydroxycarbonimidoyl)propylidene)amino]-5-(n-hydroxyformamido)pentanoic acid
C34H53N9O16 (843.3610097999999)
(2s)-3-phenyl-2-({[(3s,9s,12s,15r)-2,5,11,14-tetrahydroxy-3,9-bis[2-(4-hydroxyphenyl)ethyl]-12-isopropyl-7-methyl-8-oxo-1,4,7,10,13-pentaazacyclononadeca-1,4,10,13-tetraen-15-yl]-c-hydroxycarbonimidoyl}amino)propanoic acid
(2s)-n-[(2s,5s,8s,11r,12s,15s,18s,21r)-8-[(2s)-butan-2-yl]-6,13,16,21-tetrahydroxy-2-[(1s)-1-hydroxyethyl]-5-[(4-methoxyphenyl)methyl]-4,11-dimethyl-15-(2-methylpropyl)-3,9,22-trioxo-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-5-hydroxy-3,4-dihydro-2h-pyrrole-2-carboximidic acid
C41H61N7O12 (843.4377986000001)
(2e)-n-[(3r,4r,5r,6r)-2-{[(2r,3r,4r,5s,6r)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl]oxy}-6-[(2r)-2-[(2r,4s,5s)-3,4-dihydroxy-5-(6-hydroxy-2-oxo-3h-pyridin-3-yl)oxolan-2-yl]-2-hydroxyethyl]-4,5-dihydroxyoxan-3-yl]-13-methylpentadec-2-enimidic acid
n-[(2r,5s,8s,11r,12s,15s,18s,21r)-8-[(2s)-butan-2-yl]-6,13,16,21-tetrahydroxy-2-[(1s)-1-hydroxyethyl]-5-[(4-methoxyphenyl)methyl]-4,11-dimethyl-15-(2-methylpropyl)-3,9,22-trioxo-10-oxa-1,4,7,14,17-pentaazabicyclo[16.3.1]docosa-6,13,16-trien-12-yl]-5-hydroxy-3,4-dihydro-2h-pyrrole-2-carboximidic acid
C41H61N7O12 (843.4377986000001)
(2s)-2-{[(2r)-2-{[(2s)-2-{[(2r)-2-{[(3s,4s)-4-amino-8-{[(2,3-dihydroxyphenyl)(hydroxy)methylidene]amino}-1,3-dihydroxyoctylidene]amino}-1,3-dihydroxypropylidene]amino}-1-hydroxy-5-(n-hydroxyformamido)pentylidene]amino}-1-hydroxy-3-(c-hydroxycarbonimidoyl)propylidene]amino}-5-(n-hydroxyformamido)pentanoic acid
C34H53N9O16 (843.3610097999999)